J. Mould - Concepedia

Author

J. Mould

Queen Elizabeth Hospital Birmingham

Also Known As

J J Mould, J Mould, J. J. Mould, J. Mould, J.J Mould, J.J. Mould, JOHN J. MOULD, John J. Mould, John Mould, Mews, M.

Publications

639

Citations

H-Index

Concepts

All Affiliations

Queen Elizabeth Hospital Birmingham Cancer Research UK Clinical Trials Unit Queen Elizabeth Hospital Birmingham Women's Hospital Queen Elizabeth Hospital

About

J. Mould is an author at Queen Elizabeth Hospital Birmingham specializing in medicine, gynecology oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	476
2	Obstetrics	10	10	369
3	Public Health	6	6	271
4	Pathology	4	4	148
5	Health Sciences	1	1	17

J. Mould

Publications

522

Citations

H-Index

Page 1

	Year	Citations
Combination Bleomycin, Ifosfamide, and Cisplatin Chemotherapy in Cervical Cancer E. J. Buxton, C. A. Meanwell, C. Hilton, JNCI Journal of the National Cancer Institute Cervical Cancer ManagementCervical CancerMedicineMetronomic TherapyGynecology	1989	87
Radiotherapy in the management of vaginal intraepithelial neoplasia after hysterectomy Ciarán Woodman, J. Mould, J. A. Jordan BJOG An International Journal of Obstetrics & Gynaecology Hormone Replacement TherapySurgical OncologyUrologyVulvar DiseasesRadiation Therapy	1988	48
Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer Jeffrey Tobias, E. J. Buxton, G. Blackledge, Cancer Chemotherapy and Pharmacology Cervical Cancer ManagementCervical CancerMedicineAnti-cancer AgentCancer Treatment	1990	46
A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West midlands ovarian cancer group trial II F. Lawton, David Luesley, G. Blackledge, Clinical Oncology Gastrointestinal OncologyEpithelial Ovarian CancerMedicineGynecologyRandomized Trial	1990	46
Phase II study of ifosfamide in cervical cancer. C. A. Meanwell, J. Mould, G. Blackledge, PubMed Neuro-oncologyCervical Cancer ManagementSurgical OncologyCervical CancerRadiation Therapy	1986	43
Phase II study of mitoxantrone in epithelial ovarian cancer. F. Lawton, G. Blackledge, J. Mould, PubMed Partial ResponseEpithelial Ovarian CancerForty-six PatientsMedicinePharmacology	1987	35
Placental transfer of chlorthalidone and its elimination in maternal milk B A Mulley, G D Parr, W. K. Pau, European Journal of Clinical Pharmacology Placental TransferLactationHuman LactationMedicineMaternal Complication	1978	33
Randomized Trial Comparing Aminoglutethimide With High-Dose Medroxyprogesterone Acetate in Therapy for Advanced Breast Carcinomau PA Canney, T.J. Priestman, T.R. Leyshon Griffiths, JNCI Journal of the National Cancer Institute	1988	33
The problem of avascular necrosis of bone in patients treated for Hodgkin's disease J. Mould, Neville M. Adam Clinical Radiology Bone DiseaseSkeletal TraumaVasculitisOsteopathyPathology	1983	31
The west Midlands epithelial ovarian cancer adjuvant therapy trial C. W. E. Redman, J. Mould, Jane Warwick, Clinical Oncology MedicineGynecologyCancer TreatmentOncologyGynecology Oncology	1993	25

Page 1